These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Sphingosine-1-phosphate mediates ICAM-1-dependent monocyte adhesion through p38 MAPK and p42/p44 MAPK-dependent Akt activation. Lin CC; Lee IT; Hsu CH; Hsu CK; Chi PL; Hsiao LD; Yang CM PLoS One; 2015; 10(3):e0118473. PubMed ID: 25734900 [TBL] [Abstract][Full Text] [Related]
10. Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR. Bassi R; Dei Cas M; Tringali C; Compostella F; Paroni R; Giussani P Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895074 [TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells. Hsieh HL; Sun CC; Wu CB; Wu CY; Tung WH; Wang HH; Yang CM J Cell Biochem; 2008 Apr; 103(6):1732-46. PubMed ID: 17902169 [TBL] [Abstract][Full Text] [Related]
12. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival. Maiti A; Takabe K; Hait NC Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260 [TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate signaling in physiology and diseases. Takuwa Y; Okamoto Y; Yoshioka K; Takuwa N Biofactors; 2012; 38(5):329-37. PubMed ID: 22674845 [TBL] [Abstract][Full Text] [Related]
14. Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells. Long JS; Edwards J; Watson C; Tovey S; Mair KM; Schiff R; Natarajan V; Pyne NJ; Pyne S Mol Cell Biol; 2010 Aug; 30(15):3827-41. PubMed ID: 20516217 [TBL] [Abstract][Full Text] [Related]
15. Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in vascular endothelial cells. Gonzalez E; Kou R; Michel T J Biol Chem; 2006 Feb; 281(6):3210-6. PubMed ID: 16339142 [TBL] [Abstract][Full Text] [Related]
16. Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate. Hawkins CC; Ali T; Ramanadham S; Hjelmeland AB Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32977496 [TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness. Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934 [TBL] [Abstract][Full Text] [Related]
18. A 50-Hz magnetic-field exposure promotes human amniotic cells proliferation via SphK-S1P-S1PR cascade mediated ERK signaling pathway. Chen L; Xia Y; Lu J; Xie Q; Ye A; Sun W Ecotoxicol Environ Saf; 2020 May; 194():110407. PubMed ID: 32146198 [TBL] [Abstract][Full Text] [Related]
19. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression. Ishitsuka A; Fujine E; Mizutani Y; Tawada C; Kanoh H; Banno Y; Seishima M Int J Mol Med; 2014 Oct; 34(4):1169-74. PubMed ID: 25109763 [TBL] [Abstract][Full Text] [Related]
20. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. Tanimoto T; Lungu AO; Berk BC Circ Res; 2004 Apr; 94(8):1050-8. PubMed ID: 15044318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]